[Sensitivity of trypanosomas to metabolic inhibitors].
D000349:Africa; D000813:Anilides / Q000494:pharmacology*; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D001377:Azaserine / Q000494:pharmacology; D002417:Cattle; D002489:Central America; D014355:Chagas Disease; D003609:Dactinomycin / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D006019:Glycolysis; D006801:Humans; D007110:Immunity, Active; D007300:Insect Control; D007630:Kenya; D008937:Mitomycins / Q000494:pharmacology; D009696:Nucleic Acids / Q000378:metabolism; D011506:Proteins / Q000037:antagonists & inhibitors; D011691:Puromycin / Q000494:pharmacology; D013020:South America; D014345:Trypanosoma / Q000187:drug effects* / Q000378:metabolism; D014352:Trypanosomiasis / Q000188:drug therapy / Q000517:prevention & control*; D014353:Trypanosomiasis, African; D014354:Trypanosomiasis, Bovine
D000813:Anilides; D000890:Anti-Infective Agents; D008937:Mitomycins; D009696:Nucleic Acids; D011506:Proteins; D005467:Floxuridine; D003609:Dactinomycin; D011691:Puromycin; D001377:Azaserine
La sensibilité des trypanosomes aux inhibitorteurs mitaboliques.